SPTLC1 and Cognitive impairment: However, comparative biochemical studies on lymphoblastoid cells derived from SPTLC1-related juvenile ALS patients with and without cognitive impairment are needed to prove the assumption of the modifying impact of threshold-expression of the above-discussed proteins in the clinical manifestation of diverse symptoms of SPTLC1-pathology.